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2Summary
Cytochrome P450 monooxygenases (P450s) play crucial roles in the cell metabolism and provide an 
unsurpassed diversity of catalyzed reactions. Here, we report the identification and biochemical 
characterization of two P450s from Arthrobacter sp., a gram-positive organism known to degrade the 
opium alkaloid papaverine. Combining phylogenetic and genomic analysis suggested physiological 
roles for P450s in metabolism, and revealed potential gene clusters with redox partners facilitating the 
reconstitution of the P450 activities in vitro. CYP1232F1 catalyzes the para demethylation of 
3,4-dimethoxyphenylacetic acid to homovanillic acid while CYP1232A24 continues demethylation to 
3,4-dihydroxyphenylacetic acid. Interestingly, the latter enzyme is also able to perform both 
demethylation steps with preference for the meta position. The crystal structure of CYP1232A24, which 
shares only 29% identity to previous published structures of P450s helped to rationalize the preferred 
demethylation specificity for the meta position and also the broader substrate specificity profile. In 
addition to the detailed characterization of the two P450s using their physiological redox partners, we 
report the construction of a highly-active whole-cell E. coli biocatalyst expressing CYP1232A24, which 
formed up to 1.77 g l-1 3,4-dihydroxyphenylacetic acid. Our results revealed the P450s role in the 
metabolic pathway of papaverine enabling further investigation and application of these biocatalysts.
Keywords: Arthrobacter sp., biochemical characterization, crystal structure, cytochrome P450, 
metabolism
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3The gram-positive organism Arthrobacter sp. can be classed with the family of Micrococcaceae 
and represents the genus with the largest number of species (1). As one of the most commonly isolated 
soil bacteria, Arthrobacter sp. exhibits a remarkable adaptivity to extreme environmental conditions 
and metabolic diversity (25). In addition to the degradation of harmful aliphatic, aromatic and organic 
compounds, the bacterium is able to metabolize the naturally occurring complex opium alkaloid 
papaverine for energy supply (68). Possible metabolic pathways of the degradation of compounds such 
as papaverine, phthalates or sulfadiazines have already been postulated (6, 913) however, the enzymes 
involved are often not known or have not yet been heterologously expressed for detailed 
characterization.
The first step in the degradation of xenobiotics is often catalyzed by oxygenases, such as 
dioxygenases, or by cytochrome P450 monooxygenases (P450s). The latter enzyme system represents 
a huge and diverse superfamily, which can be categorized into families (> 40% identity) and subfamilies 
(> 55% identity). Based on the associated electron-donating redox partners, the P450s are further 
divided into different electron transfer classes (I to VIII) (14, 15). Their ability to oxyfunctionalize non-
activated carbon-hydrogen bonds using molecular oxygen under mild reaction conditions (RT, 
atmospheric pressure) renders P450s highly attractive for applications in chemical synthesis (16, 17). 
Unfortunately, the identification of novel P450s for potential industrial applications is often quite 
challenging due to the complexity of the enzyme system. For this, several factors must be overcome: I) 
functional expression of all components, II) determination of functional redox partners, which are 
mainly distributed over the whole genome, III) lack of knowledge regarding the physiological function 
of the enzymes. Although it is often possible to reconstitute the enzymes activity by non-physiological 
redox partners like eukaryotic adrenodoxin reductase and adrenodoxin from Bos taurus as well as 
putidaredoxin reductase (CamA) and putidaredoxin (CamB) from Pseudomonas putida, using the 
physical redox partners in most cases results in higher activity. However, the search for an entire 
functional multicomponent-substrate-system can be tedious and is a factor limiting the investigation 
and also the activity of P450s (18). In the last decade, interesting P450s were successfully characterized 
from metabolically diverse bacteria including Bacillus megaterium, Chondromyces apiculatus, 
Novosphingobium aromaticivorans, Rhodopseudomonas palustris and Sorangium cellulosum (1923). 
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4Nevertheless, the gap between characterized P450s and available sequences is consequently increasing 
due to progress in genome sequencing technology. Recently, the 4.8-Mb draft genome of 
Arthrobacter sp. isolated close to Hohenheim (DE), which was formerly known as Nocardia sp. was 
sequenced by our group and phylogenetically reclassified (24). In the late 1970s, metabolites 
accumulating in the medium were analyzed when this strain was cultivated on papaverine as sole carbon 
and nitrogen source (6, 9). Thus, a partial metabolic pathway of papaverine was proposed which consists 
of multiple enzymatic steps including reactions possibly catalyzed by P450s (Fig. 1). By decoding the 
genome, the investigation of four putative P450s, as well as many different oxygenases and redox 
proteins from this metabolically diverse organism was enabled. The reconstitution of P450 activity and 
identification of substrates oxyfunctionalized by these enzymes might provide novel insights into P450 
systems while revealing new biocatalysts for potential industrial applications. 
In this study, we cloned, expressed and characterized two novel P450s from Arthrobacter sp. 
which together catalyze the didemethylation of 3,4-dimethoxyphenylacetic acid (3,4-DMPA), through 
their complementary specificity for meta- and para-methoxy groups. In the course of these studies, we 
discovered a putative P450 class III system consisting of a physiological ferredoxin reductase and 
flavodoxin for electron transfer. The crystal structure of one of the enzymes, CYP1232A24, in 
combination with computer-modelling, has revealed the molecular determinants of meta specificity in 
the enzyme. Finally, efficient whole-cell recombinant biocatalysts were constructed by expressing the 
enzymes in E. coli, enlarging the biotechnological potential for selective oxyfunctionalization.
Experimental Procedures
Growth experiments with Arthrobacter sp.
The cultivation of Arthrobacter sp. was carried out in liquid culture with 20 ml MSB minimal medium 
(as described by Cohen-Bazire and Stanier (25)) containing 1% glucose at 30°C and 180 rpm overnight 
(Table S1). Testing alternative carbon sources, a preculture grown in glucose was centrifuged and 
resuspended in 200 ml MSB medium with 0.1% of the corresponding carbon source. Starting from an 
OD600 of 0.1, the optical density was measured periodically to determine growth of the organism. 
D
o
w
n
lo
a
d
e
d
 fro
m
 h
ttp
s
://a
c
a
d
e
m
ic
.o
u
p
.c
o
m
/jb
/a
d
v
a
n
c
e
-a
rtic
le
-a
b
s
tra
c
t/d
o
i/1
0
.1
0
9
3
/jb
/m
v
z
0
1
0
/5
3
1
8
3
3
8
 b
y
 U
n
iv
e
rs
ity
 S
tu
ttg
a
rt u
s
e
r o
n
 1
1
 M
a
rc
h
 2
0
1
9
5Proteomic analysis
Samples cultivated on different carbon sources were harvested at OD600 of approx. 1.6 by centrifugation 
and lysed through enzymatic and mechanical methods. The cells were resuspended in 3 ml per g cell 
wet weight (gcww) lysis buffer (20 mM Tris/HCl pH 7.5, 1 mM EDTA, 1% Triton-X, 100 mM NaCl, 
directly before use: 1 mM DTT, 20 Mg ml-1 DNase I and protease inhibitors: 1 MM Pepstatin, 0.1 mM 
AEBSF, 0.1 mM PMSF) and treated with lysozyme for 2 h at 37°C. Subsequently, the lysis was 
continued through a high-pressure homogenizer (EmulsiFlex-C5, Avestin, Ottowa, Canada) for 
5 x 5 min cycles under 1700 bar pressure. Remaining DNA was sheared by sonification on ice (Branson 
Sonifier 250 equipped with a microtip: 3 mm diameter, Danbury, USA) for 5 min (pulse: Output 5  6, 
Duty cycle: 35%). To obtain detailed information of the proteins location the lysed cells were 
centrifuged for 30 min at 55,000 x g and 4°C (Beckman Avanti J-26S XP with a JA-25.50 Rotor, 
Beckman Coulter, Brea, California, USA) to obtain the soluble (cell lysate) and insoluble (cell debris) 
fraction. The proteome of the samples was visualized through 10% and 12% SDS-PAGE. The following 
proteomic analysis was conducted by the mass spectrometry unit at the University of Hohenheim (DE). 
In this respect, the proteins were isolated from the SDS-PAGE, trypsin digested and the resulting 
peptide fragments analyzed using an ACQUITY nano-UPLC system (Waters GmbH, Milford, USA) 
directly coupled to a LTQ-Orbitrap XL hybrid mass spectrometer (Thermo Fisher Scientific, Bremen, 
Germany) as described elsewhere (26). The detected peptides were compared with a list of endogenous 
oxidation/reduction proteins derived by the genome of Arthrobacter sp. as well as with the global NCBI 
database using the MASCOT search algorithm to identify the corresponding proteins. The mass 
spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE 
(27) partner repository with the dataset identifier PXD009566 and 10.6019/PXD009566.
Genomic analysis
LGC Genomics® (Berlin, Germany) performed the global annotation of the draft genome of 
Arthrobacter sp. (24) Using this information, the corresponding ORFs of oxidation/reduction proteins 
were visualized in the software snapgene and investigated by comparison with the global NCBI 
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6database. Finally, Prof. David Nelson (Health Science Center, University of Tennessee) thankfully 
assigned the P450 families and subfamilies based on the common nomenclature.  
Cloning
The genomic DNA of Arthrobacter sp. was isolated from a preculture grown with 1% glucose using 
the Gene JET Genomic DNA Purification Kit (Thermo Fisher Scientific, Waltham, USA). The genes 
of CYP1232A24 (WP_091470958), CYP1232F1 (WP_091470959), FldX (WP_091470964), FeRed_1 
(WP_091470967) and FlavRed (WP_091470969) were amplified by PCR using the PfuUltra II fusion 
HS DNA polymerase. Appropriate primers were designed to introduce NdeI as well as EcoRI or HindIII 
restriction sites on the 3-fragment ends. Thereby, from E. coli more frequently used start and stop 
codons were introduced as required. After PCR amplification, the fragments were subsequently 
subcloned into the pET-28a(+) vector behind the poly-histidine-tag through the corresponding 
restriction sites. In case of low expression levels of the protein the gene was subcloned into pCWori+ or 
pBAD33 using the NdeI and HindIII restriction sites or Gibson Assembly®. DNA sequencing (GATC 
Biotech AG, Konstanz, Germany) verified the correct constructs. The sequences of the primers and the 
PCR procedure are given in Table S2 and S3.
Expression and purification of P450s and redox partners
The heterologous protein expression in E. coli was carried out as described previously (20) and induced 
as listed in supplementary Table S4 to start protein expression. Cells containing a protein with a poly-
histidine-tag (FldX, FeRed_1, FlavRed, CamA, CamB) were purified by immobilized metal affinity 
chromatography as described elsewhere (20). CYP1232F1 and CYP1232A24 were purified via anion 
exchange chromatography using a Toyopearl DEAE 650M XK16/40 30 ml cv column and a GigaCap 
DEAE 650M XK50/20 90 ml cv column (both Tosoh Bioscience, Griesheim, Germany), respectively, 
applying the respective buffers and conditions as described previously (20). The IMAC and IEX 
purified proteins were concentrated as well as the buffer exchanged through Vivaspin20 columns 
(cutoff 10 kDa, Sartorius, Goettingen, Germany) to 50 mM KPi pH 7.0 (150 mM NaCl, 
10 % Glycerol). Finally the proteins were aliquoted to 200 ML and stored at -20°C until use. 
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7Determination of protein concentration
The P450 concentrations were determined by CO-difference spectroscopy according to the method of 
Omura and Sato using R450-490 = 91 mM-1 cm-1 (28). The extinction coefficient of the Arthrobacter sp. 
reductase FeRed_1 was determined at 454 nm @R454 = 10.69 mM-1 cm-1) by quantification of the flavin 
content using CamA as positive control as described by Bell and co-workers (29). Novel putative 
flavodoxin FldX not showing any distinct absorption maximum in the range of 300 - 600 nm did not 
allow for specific concentration measurement. Therefore, BCA Protein Assay of the purified FldX 
solution was performed according to manufacturers instructions resulting in a protein content of 
29 ± 0.3 mg ml-1. In case of the literature known redox partners following extinction coefficients were 
used for quantification: 
- CamA: average of 378, 454 and 480 nm; (R) 9.7, 10.0 and 8.5 mM-1 cm-1 (30)
- CamB: average of 415 and 455 nm; (R) 11.1 und 10.4 mM-1 cm-1 (30)
Purities of the purified proteins were controlled by SDS-PAGE.
Purification and Crystallization of CYP1232A24
The gene encoding CYP1232A24 was subcloned into the pETYSBLIC-3C vector using protocols 
described previously (31). The recombinant plasmid was used to transform E. coli Arctic Express cells. 
A single colony of the recombinant strain was used to inoculate 10 ml of culture of TB medium 
containing 30 M ml-1 of kanamycin. This overnight culture was used for inoculation of 500 ml of the 
same medium and the cultivation was continued at 37°C shaking until a OD600 reached a value of 1.0. 
Then, the culture was induced with 0.4 mM IPTG and the medium supplemented with 0.4 mM FeSO4 
and 0.4 mM 5-Aminolevulinic acid (5-Ala). The culture was incubated overnight at 18°C with shaking. 
Cells were harvested by centrifugation for 30 min at 5,000 x g. The pellets were then resuspended in a 
buffer containing 50 mM K2PO4, 300 mM KCl, protease inhibitor (0.1 mM PMSF) and 30 mM 
imidazole at pH 7.5. The cells were disrupted using ultrasonication and the resulting suspension 
centrifuged for 45 min at 50,000 x g at 4°C. The soluble fraction was loaded onto a nickel column that 
had been pre-equilibrated with the buffer and eluted with an increasing gradient of imidazole to a 
concentration of 500 mM. Fractions containing the protein of interest were pooled together, 
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8concentrated to a volume of 500 M and loaded onto a size exclusion column (S200) that had been pre-
equilibrated with a buffer containing 50 mM Tris and 300 mM NaCl at pH 7.5. Protein-containing 
fractions were analysed on a 12% SDS-PAGE gel and the appropriate fractions were pooled together 
and concentrated using vivaspin20 columns (cutoff 10 kDa) for crystallization trials. Purity of the P450 
was estimated to be greater than 95% by SDSPAGE analysis (Fig. S1) and the protein concentration 
determined by CO-difference spectroscopy as described above.
CYP1232A24 was subjected to crystallization trials using the purified protein at a concentration 
of 15 mg ml-1 using the sitting drop vapour diffusion method in which a Mosquito robot was used to 
dispense drops of 150 nl of protein solution and 150 nl of the precipitant from a range of commercial 
screens. Crystals grew in conditions containing 0.1 M Bis-Tris propane buffer at pH 6.5, with 20% 
(w/v) polyethylene glycol monomethyl ether 5000. Crystals were harvested from these drops into a 
cryoprotectant solution containing 15% ethylene glycol in the mother liquor and were flash-cooled in 
liquid nitrogen for diffraction tests.
Data collection and refinement
A complete dataset for CYP1232A24 was collected at the Diamond Light Source (Didcot, Oxfordshire, 
United Kingdom) on beamline I04-1. The data were processed and integrated using XDS (32) and 
scaled using SCALA (33) as part of the Xia2 processing system (34). Data collection statistics are given 
in Table 1. Crystals of CYP1232A24 were in space group P21. The structure was solved applying 
MOLREP (35), using the cytochrome P450 PikC 2VZ7 (36) as the search model. The crystal contained 
one monomer in the asymmetric unit and the solvent content was 47.6%. The structure was built and 
refined using iterative cycles using Coot (37) and REFMAC (38) (Fig. S2). The final structure had Rcryst 
and Rfree values of 20.8% and 22.9%. Refinement statistics are presented in Table 1. The Ramachandran 
plot showed 95.6% of residues in allowed regions and 4.4 in preferred regions, with no outliers. The 
coordinate files and structure factors have been deposited in the Protein DataBank (PDB) with the 
coordinate accession number 6G71.
Bioinformatics tools
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9Molecular docking of 3,4-DMPA into the P450 active pocket was performed using the AutoDock Vina 
algorithm implemented in YASARA. The water molecules inside the active site and the channel were 
retained for the docking experiment. 
Substrate binding  Spin-state measurements
To determine the spin-state shifts of the novel P450s upon substrate-binding, the induced spin-shifts 
were assayed at 30°C using microtiter-plates and a plate reader (PolarStar Omega 96 well, BMG 
Labtech GmbH, Ortenberg, Germany). 1 µl of substrate (1, 5 or 50 mM stock solution in DMSO) was 
stepwise added to 200 µl of a 3 µM P450 solution in IMAC buffer and spectra between 320  480 nm 
recorded each time. The measurements were performed in triplicates while 3 µM P450 solution with 
the same volume of pure DMSO was used as reference to compensate dilution effects. A shift in 
absorbance @WA was determined by subtracting the sample with substrate from the reference. Finally, 
for the determination of the binding constants Kd, the difference W390 - W420 was plotted against the 
substrate concentration used and a hyperbolic curve was fitted applying the solver analysis tool in Excel 
(Eqn. 1): = Amax   [S]d + [S]
WA is the peak-to-trough absorbance difference, WAmax is the maximum absorbance difference and [S] 
is the substrate concentration.
In vitro assays
The in vitro reactions were carried out in a volume of 200 M in reaction buffer (50 mM KPi pH 7.0, 
150 mM NaCl, 2.5% glycerol). The glucose-6-phosphate dehydrogenase system (G6PDH from 
L. mesenteroides) was used to regenerate the cofactor NAD(P)H (12 U ml-1 G6PDH, 5 mM G6P, 1 mM 
MgCl2). Standard in vitro reactions contained 100 M ml-1 catalase, 2 mM NAD(P)H and 1 mM 
substrate (50 mM stock solution in DMSO or ethanol). All components were mixed, and the 
biotransformation was started with the addition of a mixture of P450 (lysate or purified), reductase, 
flavodoxin or ferredoxin in the stoichiometric ratio 1: 1.5: 15 (2 M; 3 M; 30 MA In the case of the 
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10
FeRed_1 and FldX redox partner system, 225 µM from purified FldX solution was used. The reactions 
were incubated for 0.5  24 h at 30°C and 180 rpm, stopped by 10 M 37% HCl or directly by organic 
solvent and then prepared for gas chromatography. Negative controls were either lysates generated by 
the expression of the empty vector, or in the case of reactions with purified P450s, all reaction 
components except the P450. Examples of investigated substrates are listed in Table S5.
NAD(P)H depletion assay and determination of coupling efficiencies
For the NAD(P)H assay, purified P450s and redox partners were used in reaction buffer employing a 
stoichiometric ratio of 1: 1.5: 15, respectively. In total 0.25 M P450 was deployed in reaction buffer 
with a final volume of 200 µl in microtiter plates. In the case of the redox partner combination FeRed_1 
and FldX, 60 µM from purified FldX solution was used. The components were mixed together with 
100 M ml-1 catalase and 0.5 mM substrate (5 mM stock solution in DMSO). After 2 min of incubation 
at 30°C, the reaction was started with 300 M NAD(P)H (5 mM stock solution in reaction buffer) and 
the decrease of NAD(P)H monitored at a wavelength of 340 nm on the plate reader as described 
elsewhere (46). After the cofactor was completely consumed, the reactions were stopped by 10 M 37% 
HCl and the product formation was later quantified through gas chromatography. The reactions were 
carried out in triplicates while reactions without substrate addition served as a reference. A new 
calibration of NAD(P)H was measured for each 96-well plate to quantify the cofactor depletion. To 
determine coupling efficiencies, the product formation was finally correlated to the cofactor depletion 
while the values of the reference were subtracted to correct the background caused by protein impurities 
(Fig. S3). 
Determination of kinetic constants
To fulfill steady-state kinetics, different enzyme concentration ratios and reaction times were tested, so 
that a maximum conversion of 10% was achieved at the lowest substrate concentration. The reactions 
were carried out in a total volume of 500 M in 50 mM KPi pH 7.0 and contained a non-limiting 
concentration of the cofactor NAD(P)H of 2 mM as well as 100 M ml-1 catalase. The latter should 
exclude the denaturation of the proteins by possibly formed hydrogen peroxide through uncoupling 
reactions. P450, CamA and CamB were used in a ratio of 1: 1.5: 15, whereas the system P450, FeRed_1 
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11
and FldX was used at 1: 1.5: 112.5. The substrate concentrations (1  1000 MA were adjusted by 
different stock solutions in DMSO, so that a DMSO concentration of 2% v/v was present in each 
reaction. First, buffer, cofactor, catalase, and substrate were mixed in 1.5 ml reaction vessels and 
incubated for 5 min at 30°C. To start the reactions, 100 M of a short-preheated enzyme mixture 
containing the P450 and redox partners were added via a multistepper and the reaction was carried out 
in a thermocycler at 30°C and 750 rpm. The following setups were used for the recorded kinetics 
prepared in triplicates:
- 0.04 M CYP1232F1 + CamA, CamB, 3,4-DMPA: 30 min
- 0.03 M CYP1232F1 + FeRed_1, FldX, 3,4-DMPA: 20 min
- 0.03 M CYP1232A24 + FeRed_1, FldX, homovanillic acid: 20 min
To stop the reaction, 50 M of 50% water/HCl solution was added and mixed by vortexing. 
Finally, the product formation was quantified by gas chromatography. Hereby obtained 
Michaelis-Menten kinetics were fitted by the Excel solver tool to determine the enzyme specific 
constants Km and kcat.
Construction and expression of whole-cell systems
Dual vector systems were created based on the compatible pETDuet and pCola or pBAD18 and 
pBAD33 vectors. The plasmids pCola_CYP1232F1_FldX, pETDuet_FldX_FeRed_1, 
pCola_CYP1232F1_CamB, pBAD18_FldX_FeRed_1 were constructed via Gibson Assembly® using 
the specific primers listed in Table S2. The fragments (vectors and inserts) amplified through PCR 
(Table S3) were controlled by an agarose gel and isolated using the Zymoclean Gel DNA Recovery 
Kit (Zymo Research Corp., Irvine, California, USA) for purification. Gibson Assembly® was finally 
performed with 15 M Gibson Assembly® mix and 5 M DNA mix (vector to insert(s), molar ratio 1:5, 
total ~ 300 ng) for 1 h at 50°C. After transformation in chemically competent E. coli XL1-blue cells, 
isolated plasmid constructs were checked for correct modification by DNA sequencing. For the whole-
cell expression, the plasmids encoding the redox partners were transformed in competent E. coli 
BL21 (DE3) or JW5510 cells to prepare chemical competent cells of these strains. As next step, the 
second plasmid encoding the P450 gene was freshly transformed with high transformation efficiency 
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each time. Expression of the three proteins was conducted as described with the sole components using 
expression temperature and inductor concentration as listed in supplementary Table S4. After 
expression of the dual-vector systems, the cells were harvested for 15 min at 6,000 x g and 4°C and the 
resulting pellets directly resuspended with 100 mM KPi pH 7.0 supplemented with 30 mM glucose (to 
0.2 gcww ml-1). 
In vivo biotransformations
The resting cell reactions were finally performed in screwable 20 ml glass reaction vessels with a 
reaction volume of 1 ml, a final cell concentration of 0.1 gcww ml-1, with 30 mM glucose and with 5 or 
10 mM substrate (250 mM or 500 mM stock solution in DMSO) for 24 h at 30°C and 180 rpm. The 
reactions were then transferred to 2 ml reaction vessels, centrifuged and the supernatant prepared for 
gas chromatography.
Product analysis
Highly volatile molecules or molecules whose volatility can be increased by derivatization have been 
analyzed by gas chromatography. For this purpose, the in vitro (200 MA or in vivo (supernatant: 750 MA 
samples were extracted with the same volume methyl tert-butyl ether (MTBE) containing 0.2 mM 
carvone as internal standard. In the case of a necessary derivatization of the analytes, acidification of 
the samples by 10 M (in vitro) or 35 M 37% HCl (in vivo) was performed before these were extracted 
with MTBE (including 0.3 mM 3-methoxyphenylacetic acid or 4-methoxycinnamic acid as internal 
standard). Before derivatization, the organic phase was evaporated on a Genevac EZ-2 Plus Evaporator 
(SP Scientific, Ipswich, United Kingdom) to dryness and the residual dissolved in a mixture of 50% 
MTBE and 50% N,O-bis(trimethylsilyl)trifluoroacetamide (BSTFA) + trimethylchlorosilane (TMCS) 
(99: 1). The derivatization of the samples (in vitro or kinetics: 90 M in vivo: 300 MA was carried out in 
GC vials for 30 min at 70°C. If product standards were available, a calibration with the authentic 
standard was treated and analyzed similar to the reactions (Table S5). Gas chromatography was 
performed on a Shimadzu GC-2010 equipped with an AOC-20i autoinjector (Shimadzu, Nakagyo-ku, 
Japan). The samples were injected with different split ratios (injector temperature 250°C, carrier gas 
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H2, 30 cm sec-1) and separated via a DB-5 or HP-1ms-ui column (both 30 m x 0.25 mm x 0.25 Mm, 
Agilent Technologies Inc., Santa Clara, California, USA). The analytes were detected by means of a 
flame ionization detector (FID, detector temperature 330°C) using the programs listed in Table S6. 
For initial product identification, the samples were afterwards analyzed on a Shimadzu GCMS-
QP2010 detector equipped with an AOC-5000 autoinjector (Shimadzu) and helium as carrier gas (linear 
velocity 30 cm sec-1). The analytes were separated via a DB-5 column and measured with identical 
temperature programs to the previous analysis. An ionization (EI, electron ionization) of 70 eV, an 
interface temperature of 250°C and an ion source temperature of 200°C were used for recording the 
mass spectra. The mass fragments were finally detected in the scan mode from 35 to 300 m/z or from 
40 to 450 m/z for the derivatized samples. The non-volatile compounds diclofenac and papaverine were 
analyzed by HPLC (Table S7).
Results
Proteomic and genomic analysis of Arthrobacter sp.
In previous work in our group, shotgun genome sequencing of Arthrobacter sp. revealed potential new 
P450 monooxygenases and many other oxidoreductases with putative hydroxylation activity (24). A 
targeted approach to identify enzymes involved in the degradation of certain molecules is proteomic 
analysis. In the case of growth on certain substances, enzymes like P450s, which are responsible for the 
observed organisms capabilities, might be overexpressed or initially induced. Arthrobacter sp. is able 
to metabolize the naturally occurring alkaloid papaverine for energy supply (6). Due to its complexity, 
papaverine is an interesting compound for which the key metabolic enzymes have not yet been 
identified and characterized. In addition to papaverine, Arthrobacter sp. metabolized valuable 
sesquiterpenes like \-bisabolene as sole carbon source. Analyzing the difference in the proteome of the 
gram-positive organism grown on different substrates, cell samples were lysed through a mixture of 
mechanical and enzymatic methods. Subsequent SDS-PAGEs already indicated variations in the protein 
bands depending on the substrate (Fig. S4). Compared to the control grown on glucose, CYP1232A24 
and F1 could be clearly identified in the proteomic analysis of the papaverine samples while no greater 
difference was observed with the other substrates (Table 2). Frequently, P450 enzymes and their 
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electron transfer partners are widely scattered on the genome. Interestingly, the genes coding for both 
these P450s are located directly successively on the genome of Arthrobacter sp. and are associated with 
a possible gene cluster. This cluster consists of a ferredoxin reductase FeRed_1, which was also 
exclusively detected in the papaverine sample, a second reductase FlavRed and a putative flavodoxin 
FldX (Fig. 2). In addition, Arthrobacter sp. contains a large range of potential P450 redox partners like 
bifunctional reductases (POR and PDR homologues), 2Fe-2S or 4Fe-4S ferredoxins and several 
reductases which are known from biological diversity (39).
Cloning, expression and activity reconstitution of Arthrobacter sp. P450s
The genes encoding the P450s and their possible physiological redox partners were amplified from the 
genomic DNA and cloned into pET-28a(+). Due to the high GC content of the gene sequences and the 
numerous rare codons, it was found that expression of the Arthrobacter sp. proteins was conducted most 
efficiently in E. coli Rosetta (DE3). Nevertheless CYP1232A24 and F1 could not be expressed in 
satisfactory amounts even after extensive experiments with further expression strains, different media 
and expression temperatures and were therefore subcloned into the vectors pCWori+ and pBAD33. This 
resulted in a huge increase in potentially active P450 enzyme enabling successful purification by anion 
exchange chromatography (Table S4 and S8). Both purified P450s could be detected according to the 
calculated molecular weight on a control SDS-PAGE (Fig. 3). In case of the potential redox partners, 
soluble target proteins were obtained by expression from pET-28a(+) in E. coli Rosetta (DE3). Only 
FeRed_1 showed unique absorption maxima in the UV spectrum at 373 and 454 nm (Fig. S5). The 
extinction coefficient at 454 nm was determined as 10.69 mM-1 cm-1 and subsequently used for 
concentration measurements. 
The identification of the right combination of enzyme, appropriate redox partners and substrate 
poses a challenge for the initial characterization of P450s. Both novel P450s could be assigned to the 
CYP1232 family of which, so far, no family members have been characterized (Table S9). The results 
from the proteomic analysis, however, provided strong indications for potential substrates for the initial 
reconstitution of activity. Fragments of CYP1232A24 and CYP1232F1 were only detected in the culture 
grown on papaverine as the sole carbon source. Since the P450s emerge in potential clusters with their 
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putative redox partners, we tested the reconstitution by these physiological redox partners FlavRed, 
FeRed_1 and FldX. Studies of the degradation products of papaverine have been carried out many years 
ago and revealed three possible P450-catalyzed reactions, such as the dihydroxylation of papaverine and 
twofold demethylation of 3,4-dimethoxyphenylacetic acid (3,4-DMPA) (Fig. 1) (6, 9). Notably, both 
enzymes showed a high demethylation activity with FeRed_1 and FldX using NADPH as a cofactor. 
While 2 µM CYP1232F1 converted the entire 2 mM 3,4-DMPA at the para position to homovanillic 
acid, a complete twofold demethylation to 3,4-DMPA occurred using 2 µM CYP1232A24. In contrast, 
hydroxylation or demethylation of papaverine was not observed in biotransformations using both 
P450s. In addition, we investigated a possible electron transfer by the non-physiological redox partners 
CamA and CamB from P. putida for activity reconstitution. Interestingly, 2 mM 3,4-DMPA was 
converted > 99% by 2 µM CYP1232F1 in combination with 3 µM CamA and 30 µM CamB, while 
CYP1232A24 showed only minimal activity. 
Substrate specificity profiles of CYP1232A24 and CYP1232F1
The reconstitution of a functional combination of P450, redox partners and the appropriate substrate 
allowed for further characterization. Determining the potential of the novel biocatalysts, we investigated 
foremost the substrate specificity profile. Hereby, CYP1232F1 was reconstituted with CamA and CamB 
while CYP1232A24 was used with FeRed_1 and FldX, respectively. 
In particular, para- and meta-substituted benzoic, phenylacetic, and cinnamic acid derivatives 
were tested (Table S5). In addition, structurally similar compounds were selected to investigate the 
influence of the acid group and the aromaticity. Since Arthrobacter sp. was able to grow on terpenes, 
we also screened compounds like \-bisabolene and \  CYP1232F1 displayed a very narrow 
substrate specificity profile (Fig. 4). 3,4-DMPA turned out to be the by far best tested substrate, as it 
was demethylated selectively in the para position to homovanillic acid completely. Among the many 
para- and / or meta-substituted carboxylic acids or aromatics, isohomovanillic acid, eugenol, 3-chloro-
4-methoxyaniline and 3-methoxyphenylacetic acid were demethylated by CYP1232F1. The activity 
was reduced clearly in case of the demethylation in meta position, as well as when the meta substituent 
was a hydroxy group.
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For CYP1232A24 a rather broad substrate specificity profile could be identified. In addition to 
differently substituted phenylacetic acid derivatives, the catalyst also accepted benzoic acids, such as 
isovanillic acid or 4-methoxycinnamic acid (Fig. 5). In contrast to CYP1232F1, CYP1232A24 
demethylated meta- and para-substituted aromatic compounds such as 3-methoxyphenylacetic acid or 
isohomovanillic acid with high activities. Furthermore, lauric acid was hydroxylated to a small extent 
in the ]-1-, ]-2- and ]-3-positions. Interestingly, hydroxylation of the terpene \  in the allylic 
position to 4-)
 \-ionone, and a demethylation of naproxen could be achieved. However, the 
highest activity was observed for homovanillic acid.
Biochemical characterization of CYP1232A24 and CYP1232F1
The in vitro biotransformations provided first indications of potential physiological substrates. In this 
respect, we determined the substrate binding by spin-state measurements to confirm the results obtained 
so far. In case of CYP1232F1, 3,4-DMPA led to a high-spin shift with the dissociation constant 
Kd = 65.1 ± 1.2 M (Fig. 6), while isohomovanillic acid showed only a slight shift to a wavelength of 
390 nm. No shift was observed for homovanillic acid as substrate. In contrast, the spin-state experiments 
with CYP1232A24 resulted in lowest dissociation constant and hence, strongest binding of 
homovanillic acid (Kd = 22.3 ± 0.4 MA (Fig. 6). The binding affinity decreased with isohomovanillic 
acid (Kd = 80.1 ± 2.1 MA over 3,4-DMPA where only minor high-spin shifts and no maximum were 
reached in the spin-state measurements using 1250 µM substrate (Fig. S6). Papaverine as substrate did 
not induce spin-state shifts in both enzymes.
Using the best identified substrates, we further investigated the efficiency of electron transfer 
and kinetic properties of the novel Arthrobacter sp. P450s. CYP1232A24 in combination with FeRed_1 
and FldX showed an NADPH oxidation rate of 87.8 ± 2.8 nmol nmolP450-1 min-1 with the substrate 
homovanillic acid (Table S10, Fig. S3). Herein, a high coupling efficiency of 87.0 ± 0.8% was obtained. 
In vitro biotransformations using these redox partners and 2 mM homovanillic acid as substrate led to 
> 99% demethylation to 3,4-dihydroxyphenylacetic acid after 30 min (Table 3). In case of CYP1232F1, 
2 mM 3,4-DMPA was selectively demethylated to yield > 99% of homovanillic acid in combination 
with FeRed_1 and FldX after 30 min. Thereby, higher NADPH oxidation rates of 
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103.8 ± 4.6 nmol nmolP450-1 min-1 could be achieved with > 99% coupling efficiency. The CYP1232F1 
system was also used to check the cofactor specificity of FeRed_1. In contrast, only low oxidation rates 
and coupling efficiencies could be measured using NADH as cofactor. In addition, the commonly 
applied CamA and CamB from P. putida were also tested as alternative redox partners to supply 
electrons to CYP1232F1, which achieved NADH oxidation rates of 28.2 ± 0.4 nmol nmolP450-1 min-1, a 
coupling efficiency of 83.7 ± 1.0% and an in vitro product formation of 88.1 ± 2.8% after 30 min. 
The conversion of homovanillic acid to 3,4-dihydroxyphenylacetic acid by CYP1232A24 
proceeded at a catalytic rate kcat = 5.23 ± 0.28 min-1 with FeRed_1 and FldX and demonstrated 
Km = 6.69 ± 0.27 M (Table 3 and Fig. 7). The reaction properties of the demethylation of 3,4-DMPA 
to homovanillic acid by CYP1232F1 were investigated with the heterologous redox partners CamA and 
CamB and the physiological redox partners FeRed_1 and FldX from Arthrobacter sp, respectively. 
With FeRed_1 and FldX, kcat was determined to be 5.40 ± 0.03 min-1 compared to 2.28 ± 0.04 min-1 
with CamA and CamB. The Km values depended on the P450 domain as well as the substrate and were 
therefore nearly identical with 5.16 ± 0.17 and 5.18 ± 0.20 M In total, the highest rates were achieved 
with the physiological redox partners. The catalytic efficiency values (kcat Km-1) reached 7.82 * 105 and 
1.05 * 106 min-1 M-1 with FeRed_1 and FldX as electron transfer partners for CYP1232A24 and 
CYP1232F1, respectively. 
Structure of CYP1232A24
The structure of CYP1232A24 was determined to a resolution of 1.7 Å. The sequence of CYP1232A24 
displays only 29% sequence identity to the closest homolog in the PDB, the P450 PikC from 
Streptomyces venezuelae  (2VZ7) (36) which was used as the model in the molecular replacement 
solution of the structure. The crystal was in the P21 space group and featured one molecule in the 
asymmetric unit. The sequence was complete in the structure save for two short sequences from 
positions 68-69 and 216-218 for which the electron density was insufficient for modelling. Analysis of 
the structure (Fig. 8A and B) using the DALI server (40) revealed that the cholesterol oxidase CYP142 
from Mycobacterium tuberculosis 2XKR (41) was the closest structure to A24, with an rmsd of 1.9 Å 
over 395 C-alpha atoms, with few major differences between secondary elements making up the 
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structure(s). A major difference in the active site of CYP1232A24 compared to either PikC or 2XKR 
was the presence of a glutamate residue E240 (Fig. 8C) that replaced a threonine residue in positions 
247 in PikC and 234 in 2XKR, respectively, which are thought to have a role in the scission of the 
dioxygen bond in the P450 catalytic cycle (41). Whilst other residues, such as proline, in CYP134A1 
(42) and alanine in P450EryF (43) and P450XplA (44) have been observed at this position, glutamate 
is rarely observed. An analysis of a 3DM P450 superfamily database (https://www.bio-prodict.com, 
(45)) comprising of over 39,000 sequences suggests that only 0.2% of P450 sequences have a glutamate 
at this position. As a substrate of CYP1232A24, 3,4-DMPA was modelled into the active site using 
AutoDock VINA implemented in YASARA (46). The result exhibiting the lowest binding energy and 
thus strongest binding is shown in Fig. 8C where the meta methoxy group of 3,4-DMPA points towards 
the heme iron. In this orientation, the charged carboxylate of 3,4-DMPA interacts with the basic amino 
acid arginine (Arg82) and the backbone carbonyl of a methionine (Met285). The benzene ring of the 
substrate is further stabilized inside the predominantly hydrophobic pocket via van der Waals and 
hydrophobic interactions, such as the stabilizing aromatic hydrophobic phenylalanine (Phe386). This 
interplay leads to the coordination of the meta methoxy group above the heme, while there is still 
enough space inside the active pocket to enable the oxyfunctionalization of more bulky substrates such 
as 4-methoxycinnamic acid or naproxen (Fig. 8D). 
Generation of efficient whole-cell biocatalysts
Due to the cofactor dependency of P450s, efficient whole-cell biocatalysts are obligatory for an 
application in industrial biocatalysis. Therefore, compatible dual-vector systems (pCola and pETDuet) 
were chosen for CYP1232F1, which permit simultaneous expression of up to four proteins under the 
control of a strong T7 promoter. Since an excess of flavodoxin or ferredoxin is crucial for high activities, 
these were cloned onto both plasmids. Furthermore, the pBAD33-compatible plasmid pBAD18 was 
selected for the co-expression of the redox partners for the whole-cell catalysis with CYP1232A24 due 
to its good expression in the pBAD33 vector and at the same time very low expression in the T7 
promoter system pET-28a(+). The plasmids were constructed by Gibson Assembly®, and recombinant 
strains transformed with these plasmids were tested in vivo for 24 h using 0.1 gcww ml-1 resting cells and 
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10 mM 3,4-DMPA or homovanillic acid. In case of the T7-based dual vectors, ~ 50% of the substrate 
3,4-DMPA was selectively converted by CYP1232F1, FeRed_1 and FldX, corresponding to 
0.93 ± 0.01 g l-1 of the product homovanillic acid (Table 3). In contrast, with CamA and CamB, a low 
in vivo activity was observed. Investigating whether this is caused by the actual activity of the P450 or 
by the redox partners themselves, cells from the same expression experiment were disrupted and the 
cell lysates subsequently analyzed by SDS-PAGE and CO-difference spectra (Table S11, Fig. S7). It 
turned out that the redox proteins were well expressed, but the CYP1232F1 was nearly completely in a 
nonfunctional state, characterized by a strong maximum at 420 nm in the CO-difference spectrum. By 
contrast, CYP1232A24 on pBAD33 was co-expressed with the compatible pBAD18 plasmid bearing 
FeRed_1 and FldX. The resulting whole-cell biocatalyst demethylated > 99% of 10 mM homovanillic 
acid, which corresponds to a product titer of 1.77 ± 0.04 g l-1 3,4-dihydroxyphenylacetic acid. 
Discussion
The identification of interesting oxygenases and possible clusters in the papaverine degrading 
Arthrobacter sp. provides insight into the function of oxygenases within the organism, putatively 
extending the available spectrum of efficient P450 catalysts for potential industrial applications. 
However, the identification of functional redox partners and suitable substrates is often a major 
challenge in exploiting the diverse, but complex, P450 enzymes from nature. In this study, proteomic 
and genomic analysis facilitated the elucidation of the physiological function of two P450s from 
Arthrobacter sp.
CYP1232A24 and F1 were detected in the proteomic analysis of Arthrobacter sp. cultures with 
papaverine as sole carbon source, implying their involvement in metabolism. The papaverine 
degradation pathway proposed by Lingens, Haase-Aschoff and Hauer (1979 and 1982) proceeds via the 
metabolite 3,4-dimethoxyphenylacetic acid, which is further processed by twofold demethylation (6, 
9). The participation of cytochrome P450 monooxygenases at this step of the metabolic pathway was 
conceivable and has been finally confirmed by this study. While CYP1232F1 also accepted electrons 
from the non-physiological redox partners CamA and CamB, the physiological partners FeRed_1 and 
FldX could efficiently reconstitute the activity of both clustered P450s CYP1232A24 and F1. FldX is a 
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putative flavodoxin, which has high similarities to the FMN components of the nitrogen monoxide 
synthase reductases. In addition to the bifunctional reductases BMR from P450 BM3 and eukaryotic 
CPR, these belong to the FAD-FMN protein family (47). FldX further shows high amino acid sequence 
identity of 40% to known flavodoxins such as the cindoxin from Citrobacter braakii. Regarding the 
FAD-containing NADPH ferredoxin reductase FeRed_1, likewise high sequence identity of 35% 
relative to the putative cindoxin reductase from C. braakii was apparent. The reconstitution of the P450 
activity by genetically clustered redox partners is rarely observed in microorganisms. In many cases, 
physiological redox partners are scattered over the entire genome and thus difficult to identify (39, 48, 
49). Previous exceptions include the well-characterized P450cam, P450cin and P450terp which occur 
in clusters with their redox partners and catalyze the first step of degradation of camphor, cineole and 
_ 
 respectively (5052). Here, P450cin is the only class III P450 system so far, which, in 
contrast to class I systems such as P450cam, transfers electrons over flavodoxin (cindoxin) instead of 
an iron-sulfur protein (ferredoxin) (53, 54). However, associated physiological cindoxin reductase has 
so far not been produced heterologously in active form enabling the characterization of the whole 
physiological system (55). Similarly, CYP1232 family members identified in this work can most likely 
classified into rare P450 class III, since they receive their electrons from the physiological putative 
flavodoxin FldX. Accordingly, CYP1232A24 and F1 are likely to represent heterologous expressed 
examples of physiological and functional class III P450 multicomponent systems consisting of FldX 
and the NADPH ferredoxin reductase FeRed_1. However, the sequence annotation of FldX as FMN-
containing flavodoxin could not be experimentally confirmed yet and is, therefore, an interesting target 
for further investigations.
Exploring different carboxylic acids revealed a quite narrow substrate specificity profile for 
CYP1232F1. The demethylation activity in the para position was significantly reduced when the 
methoxy group in the meta position was substituted by a hydroxy group (Fig. 4). Substrates bearing a 
methoxy group in the meta position, such as 3-methoxyphenylacetic acid, were accepted, nevertheless 
showing a significant loss of activity. While benzoic acid and cinnamic acid derivatives were not 
oxyfunctionalized, CYP1232F1 demethylated eugenol and 3-chloro-4-methoxyaniline, which do not 
contain any carboxy groups. In contrast, CYP1232A24 represents a relatively versatile enzyme, which 
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was able to demethylate benzoic, phenylacetic and cinnamic acid derivatives as well as many other 
substituted aromatic compounds (Fig. 5). The relatively bulky molecule naproxen was, for example, 
demethylated to the human drug metabolite 6-o-desmethylnaproxen, while \  could be 
hydroxylated to produce : )
 \  a valuable precursor of flavors (56). Generally, substrates 
bearing a methoxy group in the meta position were preferred and showed higher activity compared to 
those without this group. These findings indicate a much more flexible and larger active pocket 
compared to CYP1232F1. In CYP1232A24, modelling suggests that the meta methoxy group of 
3,4-DMPA is mainly coordinated above the heme by combined interactions of the substrate carboxylate 
with Arg82 as anchoring residue as well as hydrophobic interactions of the benzene ring in the active 
pocket. When comparing the active site residues of CYP1232A24 (Fig. 8C) with the corresponding 
residues in CYP1232F1, high similarity can be observed (Table 4) including Glu240, Arg82 and 
Phe386. The minor variations, e.g. Thr172 instead of Ala170 or Tyr286 instead of Val286, are therefore 
crucial for the determination of the regioselectivity of the enzymes that share 41% amino acid sequence 
identity in total (Fig. S8). These residues may also justify a larger active pocket of CYP1232A24 with 
considerable more space depicted by the surface display in Fig. 8D which enables the 
oxyfunctionalization of a broader panel of partially bulkier substrates. 
Finally, the results of in vitro and spin-state experiments with CYP1232A24 and F1 ultimately 
led to two possible routes in the papaverine-metabolism, with one pathway apparently preferred over 
the other. Here, 3,4-DMPA is regioselectively demethylated in the para position to homovanillic acid 
by CYP1232F1. Through further demethylation in the meta position by CYP1232A24, 3,4-
dihydroxyphenylacetic acid is produced for further degradation (Fig. 9). The alternative route could 
proceed without the participation of CYP1232F1 due to the versatile reaction spectrum of 
CYP1232A24. CYP1232A24 shows selectivity for demethylation in the meta position, nevertheless 
demethylation in the para or meta positions as well as a mix thereof is conceivable, since both resulting 
compounds were oxidized by CYP1232A24. Due to the catalytic properties of the enzymes and the 
detection of CYP1232A24 and F1 by proteomic analysis, the main proportion is presumably achieved 
over the route with both enzymes. This is consistent with the work of Hauer and co-workers (1982) in 
which homovanillic acid was detected as a metabolite in papaverine degrading Arthrobacter sp. (9). 
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The first step of this complex metabolic pathway is presumably catalyzed by an initial dihydroxylation 
of the heteroaromatic isoquinoline moiety of papaverine through a dioxygenase (6). In other microbial 
studies, different demethylated products of papaverine were isolated from biotransformations (57). 
However, such an activity towards papaverine could not be detected by CYP1232A24 and F1. The 
P450s were also not able to oxyfunctionalize the terpenes that Arthrobacter sp. utilizes as energy source. 
Therefore, the identity of other enzymes involved in the metabolism of sesquiterpenes like \-bisabolene 
and premnaspirodiene could not be resolved. Based on the proteomic analysis, further investigations 
will be carried out, which might reveal novel oxygenases for terpene oxyfunctionalization. 
The complete physiological systems of CYP1232A24 and F1 achieved very high efficiencies 
in vitro. > 99% of the electrons originating from the cofactor NADPH were transferred into product 
formation. The preference of the reductase FeRed_1 for the cofactor NADPH was significantly higher 
than that of NADH (Table S10), which can be found in many P450 reductases (58). Overall, the 
enzymes investigated achieved high catalytic efficiencies (Table 3). In comparison to the heterologous 
redox partners CamA and CamB, an approximately twofold higher specific activity and thus efficiency 
was measured with CYP1232A24 and the physiological system FeRed_1 and FldX. In fact, this was 
often found in the literature, as in the case of the exchange of CamB to the physiological ferredoxin Pux 
with CYP199A2 (59, 60). The kinetics and binding affinities achieved are generally lower compared to 
CYP199A2 and A4 from R. palustris, although partly also the physiological redox partners and 
substrates were investigated (29). Nevertheless, both Arthrobacter sp. P450s displayed high in vitro 
activities and demethylated > 99% of 2 mM substrate within 30 min. Interestingly, FeRed_1 could also 
transfer electrons to CamB that led to half of the conversion of CYP1232F1 when applying CamA and 
CamB (data not shown). 
For the generation of whole-cell systems, the combination of the compatible pBAD33 and 
pBAD18 expression vectors proved to be highly effective under the control of the strictly regulated 
arabinose promoters. This system is known to efficiently express toxic proteins (61). The high product 
yields of 1.77 g l-1 (CYP1232A24) show that the P450 as well as the redox partners are functionally 
expressed in high titers (Table 3). This result is well in line with previously described in vivo carboxylic 
acid hydroxylase systems CYP199A2 and A4 (29, 62, 63). Furthermore, CYP1232A24 was able to 
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exceed the in vivo yields of the so far only class III system P450cin (1.0 g l-1 product after 3 d) within 
24 h (64). In the case of the pETDuet and pCola system with CYP1232F1, it is possible to 
simultaneously express four proteins each under the control of its own strong T7 promoter. Using 
CYP101C1 and CYP101B1 from N. aromaticivorans, this expression system successfully generated 
efficient whole-cell biocatalysts (48, 65). However, analysis of CYP1232F1 biotransformations showed 
that the enzyme was only poorly produced and almost completely in non-functional form. In view of 
this, a strong increase using the pBAD system can be expected. The strict regulation of the expression 
in the pBAD system appears to be a decisive factor in the production of the cell-toxic P450s compared 
to the often leaky expression with T7-containing vectors (66, 67).
In summary, two novel P450s from the papaverine degrading Arthrobacter sp. have been 
expressed and their activities characterized. Investigation by genomic and proteomic analysis facilitated 
the reconstitution of the enzymes activity with clustered physiological redox partners. Accordingly, 
substrate specificity profiles, coupling efficiencies and binding as well as kinetic constants were 
determined which prove the physiological function of both CYPs in the papaverine degradation by 
Arthrobacter sp. The structure of CYP1232A24 has revealed an unusual glutamate residue in the active 
site in place of the well-conserved threonine in P450s, and modelling has suggested a basis for the 
regiopreference in the demethylation activity of the enzyme. The discovery of two functional P450 
systems which can be presumably classified into P450s of class III will enable further analysis of this 
rarely observed electron transfer system complementing P450 research. Moreover, the construction of 
efficient whole-cell biocatalysts paves the way to implement the Arthrobacter sp. P450s into synthetic 
applications taking advantage of the high regioselectivity of oxyfunctionalization. The final product 
3,4-dihydroxyphenylacetic acid is also an intermediate in the metabolism of dopamine as well as 
quercetin and exhibits antiproliferative activities (6870); thus, it can also serve as building block for 
drugs containing catechols and phenylacetic acid moieties, respectively. Recently, the spectrum of 
catalyzed reactions of the benzoic acid hydroxylase CYP199A4 could be enlarged including heteroatom 
oxidation (71). Further investigation of the substrate and reaction spectrum of CYP1232A24 in 
combination with the possibility of a rational design approach improving this enzymes properties may 
further extend its synthetic potential.
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Tables
Table 1. Data collection and refinement statistics for CYP1232A24. Numbers in brackets refer to 
data for highest resolution shells.
CYP1232A24
Beamline Diamond I04-1
Wavelength (Å) 0.91587
Resolution (Å) 52.92-1.70 (1.74-1.70)
Space Group P21
Unit cell (Å)
a = 39.39; b = 100.83; c = 
53.42 
_ = d = 90.00°; \ = 97.85
No. of molecules in the 
asymmetric unit
1
Unique reflections 44239 (3185)
Completeness (%) 97.6 (95.8)
Rmerge (%) 0.19 (0.69)
Rp.i.m. 0.16 (0.61)
Multiplicity 4.1 (3.4)
<I/(I)> 4.5 (1.2)
Overall B factor from 
Wilson plot (Å2)
18
CC1/2 0.94 (0.55)
Rcryst/ Rfree (%) 20.8/22.9
r.m.s.d 1-2 bonds (Å) 0.015
r.m.s.d 1-3 angles (o) 1.55
Avg. main chain B (Å2) 25
Avg. side chain B (Å2) 28
Avg. water B (Å2) 33
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Table 2. Proteomic analysis of Arthrobacter sp. The cells were cultivated with different carbon 
sources. The debris fractions are similar to the lysate fractions and are therefore not shown for clarity. 
The number stands for the number of clearly attributable peptide fragments to a protein. A higher 
number implies a higher probability that the protein is present in the sample. Other relevant proteins 
that could not be detected in proteome analysis (-) but can be assigned to potential clusters are also 
presented.
Carbon source
Identified proteins
(In total 76)
Molecular 
weight 
[kDa]
Glucose Papaverine
CYP1232A24 46 - 7
CYP1232F1 44 - 6
Ferredoxin reductase  FeRed_1 43 - 4
Flavodoxin  FldX 20 - -Clus
te
r 
1
Flavin reductase  FlavRed 22 - -
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Table 3. Biochemical characterization of the Arthrobacter sp. P450s in vitro and in vivo. 
CYP1232A24 and F1 were investigated with homovanillic acid and 3,4-dimethoxyphenylacetic acid, 
respectively.
Product formation
P450 Redox partner
Coupling 
efficiency a) 
[%]
Km
[µM]
kcat
[min-1]
kcat Km
-1
[min-1 M-1]
In vitro b)
[%]
In vivo c)
[g l-1]
CYP1232A24 FeRed_1/FldX 87.0 ± 0.8 6.69 ± 0.27 5.23 ± 0.28 7.82*105 99.8 ± 1.0 1.77 ± 0.04
FeRed_1/FldX 99.5 ± 0.5 5.16 ± 0.17 5.4 ± 0.03 1.05*106 99.9 ± 2.9 0.93 ± 0.01
CYP1232F1
CamA/B 83.7 ± 1.0 5.18 ± 0.20 2.28 ± 0.04 4.40*105 88.1 ± 2.8 0.06 ± 0.01
a) The coupling efficiency represents the efficiency with which the cofactor NAD(P)H is used to form the product.
b) For the determination of in vitro product formation, 2 M P450, 2 mM substrate and the G6PDH cofactor regeneration 
system were used and the reaction was stopped after 30 min by addition of HCl.
c) The analytical biotransformations were carried out in 1 ml at a cell concentration of 0.1 gcww ml-1 for 24 h using 10 mM 
substrate. The reactions with CYP1232A24 was carried out in the pBAD33/pBAD18 system and the reactions with 
CYP1232F1 in the pETDuet/pCola system.
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Table 4. Comparison of active site residues in CYP1232A24 and F1. The corresponding amino acids 
of CYP1232F1 in the 3D-space were identified by a P450 3DM database and blast search. 
CYP1232A24 and F1 have 41% amino acid identity over the whole structure. Differences between both 
enzymes are highlighted in red. The 3D numbering scheme represents the structurally conserved regions 
(core) in a (P450) superfamily and stands for an amino acid located in different proteins of the 
superfamily at the same position in three-dimensional space. - no 3DM number assigned.
3DM number - 52 57 58 139 140 143 212
CYP1232A24 Met72 Met76 Leu81 Arg82 Leu166 Ile167 Ala170 Met232
CYP1232F1 Met74 Met78 Val83 Arg84 Leu168 Val169 Thr172 Leu232
3DM number 215 219 281 282 283 284 377 378
CYP1232A24 Gly235 Glu240 Ile283 Met285 Val286 Pro287 Val385 Phe386
CYP1232F1 Ala235 Glu240 Val283 Met285 Tyr286 Pro287 Ile385 Phe386
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Figure legends
Figure 1. Postulated metabolic pathway of papaverine in Arthrobacter sp. (adapted from (6)). 
Arthrobacter sp. (formerly known as Nocardia sp.) is able to grow on the opium alkaloid papaverine as 
sole carbon and nitrogen source. A section of the postulated pathway is shown focusing on reactions 
which might be catalyzed by oxygenases. In the first step, papaverine is dihydroxylated at the 
heteroaromatic isoquinolin moiety (M1). Metabolite M2 is presumably formed via rearomatization, 
dehydration, hydrolization and reductive desamination. The cleavage of M2 to M3a and M3b is thought 
to be catalyzed by monooxygenases. 3,4-Dimethoxyphenylacetic acid (M3a) is further processed via 
demethylation steps over M4 and M5. Finally, M6 is formed by an extradiol-cleaving 3,4-
dihydroxyphenylacetate 2,3-dioxygenase. The metabolite M3b is presumably metabolized in similar 
fashion by the same enzymes. The enzymes of the metabolic pathway of papaverine are not known so 
far.
Figure 2. Potential cluster on the genome of Arthrobacter sp. The P450s identified by proteomic 
analysis with papaverine as the sole carbon source lie directly behind each other on the genome and are 
clustered with their potential redox partners in the near environment (FldX, FeRed_1 and FlavRed). 
The cluster is located on scaffold 2 (1.1 Mb), which is one of three scaffolds obtained by whole-genome 
shotgun sequencing of Arthrobacter sp. 
Figure 3. Protein purification of the P450s from Arthrobacter sp. CYP1232A24 and F1 were 
partially purified through IEX. The eluates were separated on 15% SDS gels according to their 
molecular weight. Reduced CO-difference spectra of the partially purified enzymes were recorded 
indicating mostly functional P450 at a maximum of 446 nm and 450 nm, respectively.
Figure 4. Substrate specificity profile of CYP1232F1. Substrates are grouped by the product 
formation achieved with 2 µM CYP1232F1, 3 µM CamA and 30 µM CamB using 1 mM substrate and 
G6PDH cofactor regeneration system over 24 h. Only demethylated products were oberved. 1: 3,4-
Dimethoxyphenylacetic acid, 4: Isohomovanillic acid, 5: Eugenol, 6: 3-Methoxyphenylacetic acid, 7: 
3-Chloro-4-methoxyanilin.
Figure 5. Substrate specificity profile of CYP1232A24. Substrates are grouped by the product 
formation achieved with 2 µM CYP1232F1, 3 µM FeRed_1 and 225 µM FldX solution using 1 mM 
substrate and G6PDH cofactor regeneration system over 24 h. Substrates without a methoxy group were 
hydroxylated. 1: 3,4-Dimethoxyphenylacetic acid, 2: Homovanillic acid, 4: Isohomovanillic acid, 
5: Eugenol, 6: 3-Methoxyphenylacetic acid, 7: 3-Chloro-4-methoxyanilin, 8: \ , 9: Isovanillic 
acid, 10: 4-Methoxybenzoic acid, 11: 4-Methoxycinnamic acid, 12: Naproxen, 13: Lauric acid, 14: 
Guajacole, 15: 3-Hydroxy-4-methoxybenzaldehyde, 16: 3-Methylanisol.
Figure 6. Spin state spectra of CYP1232F1 and CYP1232A24 from Arthrobacter sp. Substrate 
solutions of varying concentration (in DMSO) were added stepwise to a 3 MM P450 solution until 
substrate saturation (Amax) was reached. The high-spin shift WA was obtained by subtraction with the 
reference (P450 sample without substrate). Only selected spectra are shown. For the determination of 
the dissociation constant Kd, WA was plotted against the applied subtrate concentration and fitted in 
Excel using a hyperbolic curve. The measurements were performed in triplicates. A) CYP1232F1 with 
3,4-dimethoxyphenylacetic acid (1); B) CYP1232A24 with homovanillic acid (2); C) CYP1232A24 
with isohomovanillic acid (4).
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Figure 7. Determination of kinetic constants of Arthrobacter sp. P450s. The following reactions 
were analyzed: A) CYP1232A24 with FeRed_1 and FldX catalyzed demethylation of homovanillic acid 
(2) to 3,4-dihydroxyphenylacetic acid (3); B) CYP1232F1 catalyzed demethylation of 
3,4-dimethoxyphenylacetic acid (1) in para position to homovanillic acid (2) via the redox partners 
CamA and CamB or C) with FeRed_1 and FldX. The measurements were carried out in triplicates and 
the kinetic constants kcat and Km were determined by fitting with the Excel solver software. 
Figure 8. Crystal structure and molecular docking of CYP1232A24. A) Monomer of CYP1232A24 
with the heme in orange. Dotted purple lines represent gaps at positions 68-69 and 216-218; B) Surface 
display of CYP1232A24 showing the entrance to the active site; C) Docking of 
3,4-dimethoxyphenylacetic acid as substrate (green) using the AutoDock Vina algorithm implemented 
in YASARA. The residues forming the active site are shown in grey; red: oxygens; blue: nitrogens; 
yellow: sulphurs; magenta: iron. D) Surface display of the active site viewing from the substrate tunnel 
onto the heme.
Figure 9. Participation of CYP1232A24 and F1 in the metabolic pathway of papaverine in 
Arthrobacter sp. The scheme was derived from Lingens, Haase-Aschoff, and Hauer (6, 9). Papaverine 
is processed to 3,4-dimethoxyphenylacetic acid (1) over several steps. Black route: Using the 
physiological electron transfer partners FeRed_1 and FldX the following degradation proceed through 
the sequential demethylation by CYP1232A24 and F1 via homovanillic acid (2) to 3,4-
dihydroxyphenylacetic acid (3); Orange route: Both demethylation steps are catalyzed by 
CYP1232A24.
D
o
w
n
lo
a
d
e
d
 fro
m
 h
ttp
s
://a
c
a
d
e
m
ic
.o
u
p
.c
o
m
/jb
/a
d
v
a
n
c
e
-a
rtic
le
-a
b
s
tra
c
t/d
o
i/1
0
.1
0
9
3
/jb
/m
v
z
0
1
0
/5
3
1
8
3
3
8
 b
y
 U
n
iv
e
rs
ity
 S
tu
ttg
a
rt u
s
e
r o
n
 1
1
 M
a
rc
h
 2
0
1
9
 F
ig
u
re
 2
. 
P
o
te
n
ti
a
l 
c
lu
s
te
r 
o
n
 t
h
e
 g
e
n
o
m
e
 o
f 
A
r
t
h
r
o
b
a
c
t
e
r
 s
p
. 
1
6
4
x
5
0
m
m
 (
3
0
0
 x
 3
0
0
 D
P
I)
 
Downloaded from https://academic.oup.com/jb/advance-article-abstract/doi/10.1093/jb/mvz010/5318338 by University Stuttgart user on 11 March 2019
 F
ig
u
re
 3
. 
P
ro
te
in
 p
u
ri
fi
c
a
ti
o
n
 o
f 
th
e
 P
4
5
0
s
 f
ro
m
 A
r
t
h
r
o
b
a
c
t
e
r
 s
p
. 
1
6
5
 



m
m
 (
3
0
0
 x
 3
0
0
 D
P
I)
 
Downloaded from https://academic.oup.com/jb/advance-article-abstract/doi/10.1093/jb/mvz010/5318338 by University Stuttgart user on 11 March 2019
 F
ig
u
re
 4
.
 

b





	
s
p
e
c
if
ic
i 
t
 p
ro
fi
le
 o
f 
C
Y




3
2
F
1
. 
7
8
x
5
9
m
m
 (
3
0
0
 x
 3
0
0
 D
P
I)
 
Downloaded from https://academic.oup.com/jb/advance-article-abstract/doi/10.1093/jb/mvz010/5318338 by University Stuttgart user on 11 March 2019
 F
ig
u
re
 5
.









s
p
e
c
if
ic
i 

 p
ro
fi
le
 o
f 





3
2
A
2
4
. 
1
6
5
x
6
0
m
m
 (
3
0
0
 x
 3
0
0
 D
P
I)
 
Downloaded from https://academic.oup.com/jb/advance-article-abstract/doi/10.1093/jb/mvz010/5318338 by University Stuttgart user on 11 March 2019
 F
ig
u
re
 6
. 
S
p
in
 s
ta
te
 s
p
e
c
tr
a
 o
f 
C
Y
P
1
2
ff
2
F
1
 a
n
d
 C
fi
fl
ffi
2
ff
2
3
2

!
ro
m
 A
r
t
h
r
o
b
a
c
t
e
r
 s
p
. 
1
6
5
x
1
3
5
m
m
 (
3
0
0
 x
 3
0
0
 D
P
I)
 
Downloaded from https://academic.oup.com/jb/advance-article-abstract/doi/10.1093/jb/mvz010/5318338 by University Stuttgart user on 11 March 2019
 F
ig
u
re
 7
. 
D
e
te
rm
in
a
ti
o
n
 o
f
"
#
$
%
&
#
'
'
(
$
s
ta
n
ts
 o
f 
A
r
t
h
r
o
b
a
c
t
e
r
 s
p
. 
P
)
*
+
,
-
 
1
6
)
4
.
/
0
m
m
 (
3
0
0
 x
 3
0
0
 D
P
I)
 
Downloaded from https://academic.oup.com/jb/advance-article-abstract/doi/10.1093/jb/mvz010/5318338 by University Stuttgart user on 11 March 2019
 F
ig
u
re
 8
.
1
6
7
8
9
:
l
 s
tr
u
c
tu
re
 a
n
d
 m
o
l
e
c
u
l
a
r 
d
o
c
k
in
g
 o
f 
C
Y
P
1
;
<
;
=
;
>
?
;
<
>
@
A
B
D
m
m
 (
3
0
0
 x
 3
0
0
 D
P
I)
 
Downloaded from https://academic.oup.com/jb/advance-article-abstract/doi/10.1093/jb/mvz010/5318338 by University Stuttgart user on 11 March 2019
 F
ig
u
re
 9
. 
P
a
rt
ic
ip
a
ti
o
n
 o
f
E
F
G
H
I
J
I
K
I
L
M
n
d
 F
1
 i
n
 t
h
e
 m
e
N
M
O
Q
R
S
T
U
M
N
h
w
a
y
Q
V
 p
a
U
M
p
e
ri
n
e
 i
n
 A
r
t
h
r
o
b
a
c
t
e
r
 s
p
. 
1
6
L
W
X
I
Z
m
 (
3
0
0
 x
 3
0
0
 D
P
I)
 
Downloaded from https://academic.oup.com/jb/advance-article-abstract/doi/10.1093/jb/mvz010/5318338 by University Stuttgart user on 11 March 2019
